Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment
Margaret E. MaesiD, Gabriele M WögensteiniD, Gloria ColomboiD, Raquel Casado-PolancoiD, Sandra SiegertiD
Abstract
Adeno-associated viruses (AAVs) are widely used to deliver genetic material in vivo to distinct cell types such as neurons or glial cells allowing for targeted manipulation. Transduction of microglia is mostly excluded from this strategy likely due to the cells heterogeneous state upon environmental changes, which makes AAV design challenging. Here, we established the retina as a model system for microglial AAV validation and optimization. First, we show that AAV2/6 transduced microglia in both synaptic layers, where layer preference corresponds to the intravitreal or subretinal delivery method. Surprisingly, we observed significantly enhanced microglial transduction during photoreceptor degeneration. Thus, we modified the AAV6 capsid to reduce heparin binding resulting in increased microglial transduction in the outer plexiform layer. Finally, to improve microglial-specific transduction, we validated a Cre-dependent transgene delivery cassette.Together, our results provide a foundation for future studies optimizing AAV-mediated microglia transduction and highlight that environmental conditions influence microglial transduction efficiency.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 12
- FWCI
- 1.13
- Field percentile
- top 24%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in mice
Miguel C. Santoscoy, Paula Espinoza, … Casey A. Maguire·bioRxiv·Sep 25, 2024
- Comparative analysis of microglia-targeted AAVs reveals capsid choice drives efficiency in vitro but has limited impact in vivo
Saša Jereb, Lia R. D’Alessandro, … Benjamin E. Deverman·bioRxiv·Aug 5, 2026
- Optimization of AAV tools to target Müller glial cells for retinal gene therapy
Daniel Urrutia-Cabrera, Genevieve Huppert, … Raymond C.B. Wong·bioRxiv·Apr 11, 2026
- Optimization of AAV tools to target Muller glial cells for retinal gene therapy
Daniel Urrutia-Cabrera, Genevieve Huppert, … Raymond C.B. Wong·Molecular Therapy AdvancesPeer-reviewed·Jul 3, 2026
- AAV2-Retro-Mediated Gene Transfer Selectively Targets Outer Retinal Cells Following Intravitreal Injection
Chaimaa Kinane, Moxa Panchal, … Kevin Kyungsuk Park·Investigative Ophthalmology & Visual SciencePeer-reviewed·Mar 27, 2026
- Microglia-specific transduction via AAV11 armed with IBA1 promoter and miRNA-9 targeting sequences
Nengsong Luo, Kunzhang Lin, … Fuqiang Xu·bioRxiv·Jul 9, 2024